Abeona Therapeutics (ABEO) Tops Q1 EPS by 4c

Abeona Therapeutics (NASDAQ: ABEO) reported Q1 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $8.72 million versus the consensus estimate of $4.62 million.

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities